Market Report Source

Overview

Introduction

Martek Biosciences (Martek) is a life-science based company that develops and commercializes naturally produced products derived from microalgae, fungi and other microbes. It’s research is focused on identifying and creating commercially viable products for the nutraceutical, pharmaceutical and functional foods markets.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Martek’s product focus is the development of nutritional products derived from microalgae, fungi and other microbes for the treatment of diseases in the area of inflammation, cognitive function and cardiovascular health. It has developed and patented two fermentable strains of microalgae which produce oils rich in docosahexaenoic acid (DHA). A similar patented process was developed for a fungus that produces an oil rich in arachidonic acid, ARA. Both DHA and ARA are important nutrients for optimal infant development. It’s product folio includes Neuromins brand DHA supplements containing life’sDHA is a vegetarian source of docosahexaenoic acid, DHA for pregnant women. Martek derives majority of its revenues from the product sales of infant formula that contains nutritional oils as well as from the product sales of Neuromins, a DHA dietary supplement. It also generates revenues through contract manufacturing for the production of enzymes, specialty chemicals, vitamins and agricultural specialty products.

Reasons to Purchase

Access all the important information and analysis on the company in a single report Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company’s adjusted five year financial data along with key ratios and market capitalization.

Table of Contents

Overview
Catalyst
Summary
Company Structure
Company Overview and Key Facts
Business Description
History
Locations and Subsidiaries
Company Financials
Stock Market Performance
P&L
Balance Sheet
Cash Flow
Business Segment Performance
Products & Services
Marketed Products
Competitors and Strategic Business Relationships
Top Competitors
Key Suppliers
Key Clients
Shareholding Structure
Strategy
Company View
Corporate Strategy
SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Value Chain Analysis
Overview
Discovery and Product Development
Manufacturing
Sales
Key Employees
List of Key Employees
Key Employee Biographies
Financial and Operational Overview
Financial and Operational Overview
Appendix
Ask the analyst
Datamonitor consulting
Disclaimer

FIGURES
Figure 1: Martek Biosciences – Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Figure 2: Martek Biosciences – Key Strategic Revenues, 2002-2006 ($ Mn)

TABLES
Table 1: Martek Biosciences – Key Facts
Table 2: Martek Biosciences – Other Locations and Subsidiaries
Table 3: Martek Biosciences – Year-End Share Price and Market Capitalization, 2002-2006 ($)
Table 4: Martek Biosciences – Key Events Impacting Share Price Performance
Table 5: Martek Biosciences – Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
Table 6: Martek Biosciences – Operating Cost Ratio Analysis, 2002-2006 (% of total revenues)
Table 7: Martek Biosciences – Balance Sheet, 2002-2006 ($ Mn)
Table 8: Martek Biosciences – Cash Flow, 2002-2006 ($ Mn)
Table 9: Martek Biosciences – Revenue Breakdown, 2002-2006 ($ Mn)
Table 10: Martek Biosciences – Marketed Products
Table 11: Martek Biosciences – Top Competitors
Table 12: Martek Biosciences – Key Clients
Table 13: Martek Biosciences – Key Shareholders
Table 14: Martek Biosciences – SWOT Analysis Summary
Table 15: Martek Biosciences – Value Chain Analysis
Table 16: Martek Biosciences – Key Employees
Table 17: Martek Biosciences – Financial and Operational Overview